Overview
This study aims to evaluate the effectiveness of midodrine as an adjuvant to norepinephrine in weaning critically ill patients from vasopressors
Eligibility
Inclusion Criteria:
- Patients with refractory hypotension on an intravenous vasopressor for more than 24 h but deemed clinically stable.
- Patients on noradrenaline support <10 μg/min
Exclusion Criteria:
- Known allergy to midodrine.
- Severe shock state, as evidenced by multiple vasopressor infusions or high vasopressor requirement (i.e. noradrenaline >10 μg/min)
- Patients with severe organic heart disease (e.g., heart failure, sever aortic stenosis), pregnancy, thyrotoxicosis or pheochromocytoma.
- Those with no enteral route available.